{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:18:12Z","timestamp":1789391892932,"version":"build-2803163510"},"reference-count":30,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T00:00:00Z","timestamp":1643241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Canadian Cancer Society","award":["400391"],"award-info":[{"award-number":["400391"]}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["YI2012"],"award-info":[{"award-number":["YI2012"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>ARPC1B (Actin Related Protein 2\/3 Complex Subunit 1B) has been found to be involved in platelet abnormalities of immune-mediated inflammatory disease and eosinophilia. However, its role in prostate cancer (PCa) has not been established. We characterized the role of ARPC1B in PCa invasion and metastasis and investigated its prognosis using in vitro cellular models and PCa clinical data. Higher immunohistochemistry (IHC) expressions of ARPC1B were observed in localized and castrate resistant PCa (CRPC) vs. benign prostate tissue (p &lt; 0.01). Additionally, 47% of patients with grade group 5 (GG) showed high ARPC1B expression vs. other GG patients. Assessing ARPC1B expression in association with two of the common genetic aberrations in PCa (ERG and PTEN) showed significant association to overall and cause-specific survival for combined assessment of ARPC1B and PTEN, and ARPC1B and ERG. Knockdown of ARPC1B impaired the migration and invasion of PC3 and DU145 PCa cells via downregulation of Aurora A kinase (AURKA) and resulted in the arrest of the cells in the G2\/M checkpoint of the cell cycle. Additionally, higher ARPC1B expression was observed in stable PC3-ERG cells compared to normal PC3, supporting the association between ERG and ARPC1B. Our findings implicate the role of ARPC1B in PCa invasion and metastasis in association with ERG and further support its prognostic value as a biomarker in association with ERG and PTEN in identifying aggressive phenotypes of PCa cancer.<\/jats:p>","DOI":"10.3390\/ijms23031476","type":"journal-article","created":{"date-parts":[[2022,1,27]],"date-time":"2022-01-27T22:00:56Z","timestamp":1643320856000},"page":"1476","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["ARPC1B Is Associated with Lethal Prostate Cancer and Its Inhibition Decreases Cell Invasion and Migration In Vitro"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9980-2107","authenticated-orcid":false,"given":"Yaser","family":"Gamallat","sequence":"first","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada"},{"name":"Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Zaaluk","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada"},{"name":"Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4282-8012","authenticated-orcid":false,"given":"Ealia Khosh","family":"Kish","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada"},{"name":"Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramy","family":"Abdelsalam","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada"},{"name":"Alberta Precision Laboratories, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5104-835X","authenticated-orcid":false,"given":"Konstantinos","family":"Liosis","sequence":"additional","affiliation":[{"name":"Department of Computer Science, University of Calgary, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunita","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB T6G 2R7, Canada"},{"name":"Departments of Mathematical and Statistical Sciences, University of Alberta, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9190-5088","authenticated-orcid":false,"given":"Tarek A.","family":"Bismar","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2V 1P9, Canada"},{"name":"Departments of Oncology, Biochemistry and Molecular Biology, Calgary, AB T2V 1P9, Canada"},{"name":"Tom Baker Cancer Center, Arnie Charbonneau Cancer Institute, Calgary, AB T2V 1P9, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21654","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1167\/iovs.05-0810","article-title":"Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy","volume":"47","author":"Kumagai","year":"2006","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5600","DOI":"10.1172\/JCI129388","article-title":"Loss of ARPC1B impairs cytotoxic T lymphocyte maintenance and cytolytic activity","volume":"129","author":"Randzavola","year":"2019","journal-title":"J. Clin. Investig."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrm2026","article-title":"The ARP2\/3 complex: An actin nucleator comes of age","volume":"7","author":"Goley","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1083\/jcb.138.2.375","article-title":"The human Arp2\/3 complex is composed of evolutionarily conserved subunits and is localized to cellular regions of dynamic actin filament assembly","volume":"138","author":"Welch","year":"1997","journal-title":"J. Cell Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"690151","DOI":"10.3389\/fmolb.2021.690151","article-title":"Identification of Arp2\/3 Complex Subunits as Prognostic Biomarkers for Hepatocellular Carcinoma","volume":"8","author":"Huang","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1160\/TH14-04-0298","article-title":"The role of actin-binding proteins in the control of endothelial barrier integrity","volume":"113","author":"Schnoor","year":"2015","journal-title":"Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"a018267","DOI":"10.1101\/cshperspect.a018267","article-title":"The Actin Cytoskeleton and Actin-Based Motility","volume":"10","author":"Svitkina","year":"2018","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ceb.2010.10.007","article-title":"New mechanisms and functions of actin nucleation","volume":"23","author":"Welch","year":"2011","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"678030","DOI":"10.3389\/fimmu.2021.678030","article-title":"Defective Neutrophil Transendothelial Migration and Lateral Motility in ARPC1B Deficiency Under Flow Conditions","volume":"12","author":"Kempers","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_11","first-page":"45","article-title":"Silencing of the ARP2\/3 complex disturbs pancreatic cancer cell migration","volume":"33","author":"Rauhala","year":"2013","journal-title":"Anticancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"235.e1","DOI":"10.1016\/j.urolonc.2015.11.015","article-title":"SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development","volume":"34","author":"Huang","year":"2016","journal-title":"Urol. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2559.2011.04116.x","article-title":"Interactions and relationships of PTEN, ERG, SPINK1 and AR in castration-resistant prostate cancer","volume":"60","author":"Bismar","year":"2012","journal-title":"Histopathology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1593\/neo.131604","article-title":"Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition","volume":"15","author":"Han","year":"2013","journal-title":"Neoplasia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4081\/aiua.2021.1.84","article-title":"Clinical impact of combined PTEN and ERG rearrangements in localized prostate cancer","volume":"93","author":"Fragkoulis","year":"2021","journal-title":"Arch. Ital. Urol. Androl."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/modpathol.2016.154","article-title":"Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy","volume":"29","author":"Lahdensuo","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/s41391-020-00314-z","article-title":"Early-onset metastatic and clinically advanced prostate cancer is a distinct clinical and molecular entity characterized by increased TMPRSS2-ERG fusions","volume":"24","author":"Chalmers","year":"2021","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/PAI.0000000000000732","article-title":"PTEN Loss in a Prostate Cancer Cohort from Jordan","volume":"28","author":"Alzoubi","year":"2020","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1593\/neo.04130","article-title":"High-resolution genomic and expression profiling reveals 105 putative amplification target genes in pancreatic cancer","volume":"6","author":"Mahlamaki","year":"2004","journal-title":"Neoplasia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1083\/jcb.200908050","article-title":"Arpc1b, a centrosomal protein, is both an activator and substrate of Aurora A","volume":"190","author":"Molli","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3892\/or.2013.2669","article-title":"Expression of the Arp2\/3 complex in human gliomas and its role in the migration and invasion of glioma cells","volume":"30","author":"Liu","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/jcb.29136","article-title":"ARPC4 promotes bladder cancer cell invasion and is associated with lymph node metastasis","volume":"121","author":"Xu","year":"2020","journal-title":"J. Cell Biochem."},{"key":"ref_23","first-page":"2847","article-title":"Short interfering RNA-mediated silencing of actin-related protein 2\/3 complex subunit 4 inhibits the migration of SW620 human colorectal cancer cells","volume":"15","author":"Su","year":"2018","journal-title":"Oncol. Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/jhg.2011.126","article-title":"Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma","volume":"57","author":"Moriya","year":"2012","journal-title":"J. Hum. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrm2946","article-title":"Cell cycle: ARPC1B\u2014A regulator of regulators","volume":"11","author":"Skinner","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17978","DOI":"10.1038\/s41598-017-18210-3","article-title":"The expression of AURKA is androgen regulated in castration-resistant prostate cancer","volume":"7","author":"Kivinummi","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1158\/0008-5472.CAN-05-2796","article-title":"Targeting Aurora kinases for the treatment of prostate cancer","volume":"66","author":"Lee","year":"2006","journal-title":"Cancer Res."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Ton, A.T., Singh, K., Morin, H., Ban, F., Leblanc, E., Lee, J., Lallous, N., and Cherkasov, A. (2020). Dual-Inhibitors of N-Myc and AURKA as Potential Therapy for Neuroendocrine Prostate Cancer. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218277"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1007\/s00432-015-2096-x","article-title":"ERG expression in prostate cancer: Biological relevance and clinical implication","volume":"142","author":"Zhao","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/pros.23914","article-title":"Clonal evaluation of early onset prostate cancer by expression profiling of ERG, SPINK1, ETV1, and ETV4 on whole-mount radical prostatectomy tissue","volume":"80","author":"Lu","year":"2020","journal-title":"Prostate"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1476\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:09:12Z","timestamp":1760134152000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/3\/1476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,27]]},"references-count":30,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,2]]}},"alternative-id":["ijms23031476"],"URL":"https:\/\/doi.org\/10.3390\/ijms23031476","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,27]]}}}